5 Prostate Cancer Clinical Trials in Gilbert, AZ (2026)

Q: How do I join a clinical trial in Gilbert?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Gilbert research site will contact you.

Recruiting Prostate Cancer Studies in Gilbert

NCT03678025Recruiting

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer...

Gilbert, AZPHASE31,273 participantsSWOG Cancer Research Network

View Study Details

NCT07028853Recruiting

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

This study will explore whether a combination of the investigational drug mevrometostat (PF-06821497) and enzalutamide will work better than taking enzalutamide alone in participants with mCSPC who ar...

Gilbert, AZPHASE31,000 participantsPfizer

View Study Details

NCT06764485Recruiting

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

The purpose of this study is to compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate Cancer....

Gilbert, AZPHASE3960 participantsCelgene

View Study Details

NCT06629779Recruiting

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

This study will explore whether a combination of the investigational drug PF-06821497 and enzalutamide will work better than taking enzalutamide alone in participants with mCRPC who are ARSi or abirat...

Gilbert, AZPHASE3900 participantsPfizer

View Study Details

NCT03972657Recruiting

A Trial to Find Out if REGN5678 is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

The main purpose of this study is to determine the safety, tolerability (how your body reacts to the drug) and effectiveness (ability to treat your cancer) of REGN5678 alone, or in combination with ce...

Gilbert, AZPHASE1345 participantsRegeneron Pharmaceuticals

View Study Details

About Prostate Cancer Clinical Trials in Gilbert

Prostate cancer develops in the prostate gland and is one of the most common cancers in men. Many prostate cancers grow slowly, but some can be aggressive. Treatment options range from active surveillance to surgery, radiation, and hormone therapy.

There are currently 5 prostate cancer clinical trials recruiting participants in Gilbert, AZ. These studies are seeking a combined 4,478 participants. Research is being sponsored by SWOG Cancer Research Network, Pfizer, Celgene and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Prostate Cancer Clinical Trials in Gilbert — FAQ

Are there prostate cancer clinical trials in Gilbert?

Yes, there are 5 prostate cancer clinical trials currently recruiting in Gilbert, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Gilbert?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gilbert research site will contact you about next steps.

Are clinical trials in Gilbert free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gilbert studies also compensate for your time and travel.

What prostate cancer treatments are being tested?

The 5 active trials in Gilbert are testing new therapies including novel drugs, biologics, and treatment approaches for prostate cancer.

Data updated July 20, 2026 from ClinicalTrials.gov